IV Infusion Therapy – $450 per In-Office Session
What Is Ketamine IV Infusion Therapy?
Ketamine IV Infusion Therapy is a cutting-edge, FDA-approved treatment designed to stimulate healthy neurotransmitters, restore neural connections, and support mental wellness. It’s delivered directly into the bloodstream via an intravenous (IV) infusion—a method known for its rapid absorption, precise dosing, and reliable results.
Why Choose IV Infusion Therapy?
- Fast-Acting Relief: Many patients report improved mood and overall well-being within hours after the first treatment.
- Safety & Tolerability: Administered in-office under medical supervision, with vital signs monitored throughout and a brief 40-minute infusion session.
- Non-Addictive Alternative: Ketamine IV is considered a safe, non-addictive option when compared to conventional pharmacotherapies.
Conditions Treated with IV Ketamine Infusion
IV Infusion Therapy is effective for addressing treatment-resistant mental health conditions and certain pain syndromes, including:
- Severe or chronic depression
- Treatment-resistant depression (TRD)
- Postpartum depression (PPD)
- Bipolar disorder, PTSD, OCD, social anxiety
- Suicidal ideation
- Chronic pain syndromes (e.g., neuropathic pain, fibromyalgia, CRPS)
Session Details & Pricing
- Service: IV Ketamine Infusion (in-office)
- Price: $450 per session
- Procedure: 40-minute intravenous session; patients remain awake but deeply relaxed during infusion
Note: Patients should abstain from food for at least 4 hours beforehand and arrange transportation post-session due to possible grogginess or dream-like sensations.
What to Expect During Your Visit
- Before the Infusion: Avoid eating for 4 hours beforehand and plan for safe transportation afterward.
- During the Infusion: Comfortable setting, IV placed, and vital signs monitored. Most clients experience relaxation, and some report mild “out-of-body” or dream-like sensations.
- Aftercare: Side effects are typically mild and short-lived—common reactions include dizziness, blurred vision, or nausea.
Treatment Personalization & Timeline
- Individualized Plans: Each treatment protocol is customized to your needs, with flexibility for ongoing maintenance programs as needed.
- Results: While initial improvements may occur quickly, effects can last for several months. Maintenance support may be recommended.
Why This Service Stands Out
- Competitive Pricing: At $400 per session, this treatment offers premium, physician-supervised Ketamine IV therapy at a competitive rate.
- Evidence-Based Approach: Delivered in-office by trained professionals, following protocols proven effective for mood disorders and selected pain conditions.
- Fast Symptom Relief: Known for its rapid onset, IV ketamine infusion is particularly effective for severe or treatment-resistant cases.
FAQs
How many sessions are typically needed?
Treatment duration varies by individual. Many patients feel better after just a few sessions, and subsequent maintenance treatments can help sustain benefits.
Is ketamine IV infusion addictive or habit-forming?
No. Administered under professional supervision in a controlled clinical setting, ketamine has minimal addiction risk when used appropriately.
What side effects should I anticipate?
Side effects tend to be mild and temporary—common symptoms include dizziness, blurred vision, or nausea, usually resolving within a few hours post-treatment.
Will I feel intoxicated after the session?
You might experience a dreamy or dissociated sensation, often described as an “out-of-body” experience, that fades within an hour.
Can I drive myself home?
No—because of lingering effects post-infusion, you should arrange secure transportation home.
Summary Table
| Aspect | Details |
| Treatment | Ketamine IV Infusion Therapy (in-office) |
| Price | $400 per session |
| Duration | Approximately 40 minutes |
| Key Benefits | Rapid symptom relief for depression, anxiety, pain |
| Side Effects | Mild and temporary (e.g., dizziness, nausea) |
| Experience | Deep relaxation, possible dream-like sensation |
| Who Benefits | Patients with treatment-resistant conditions |